top button
    Got Questions


Global IoT Summit 2018
Oct 31, 2018
The Leela Palace, Bangalore



    Connect to us
      Facebook Login
      Site Registration Why to Join

Facebook Login
Site Registration

Angiography Devices Market: Technological Growth Map with an Impact-Analysis

0 votes
2 views

The global market for angiography devices is highly competitive in nature with a large number of players operating in it across the globe, states a new research report published by Transparency Market Research. The expansion of the product portfolio and the rising research and development activities are the key factors that are projected to enhance the growth of the level of competition in the next few years. Some of the key players operating in the angiography devices market across the globe are AngioDynamics, Medtronic Inc., GE Healthcare, Merit Medical Systems, Siemens Healthcare, Shimadzu Corporation, Koninklijke Philips N.V., Boston Scientific Corporation, Canon Medical Systems Corporation, and Cordis Corporation. Furthermore, the rapid development of the healthcare systems and the innovations in this field are some of the other major factors that are projected to encourage the growth of the overall market throughout the forecast period.

According to the market research study by Transparency Market Research, the global market for angiography devices is estimated to reach a value of US$33,370.3 mn by the end of 2025. The market is likely to register a healthy 4.30% CAGR between 2017 and 2025.

Planning To Lay Down Future Strategy? Request Brochure Of Angiography Devices Market

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=40136

Presence of Key Players to Drive Angiography Devices Market in North America

The global market for angiography devices has been classified on the basis of geography into the Middle East and Africa, North America, Latin America, Europe, and Asia Pacific. In the last few years, North America accounted for a large share of the market and is estimated to remain in the similar position in the next few years. The presence of several leading players and the advanced healthcare facilities are the key factors that are projected to accelerate the growth of the North America in the next few years. On the other hand, Asia Pacific is predicted to register a healthy growth rate in the coming few years. The rising consumer awareness and the increasing disposable income are projected to accelerate the growth of this region in the near future.

The global angiography devices market has been bifurcated on the basis of technology into CT, X-ray, MRI, and others. The X-ray segment is projected to experience a healthy growth rate in the next few years and is likely to remain in the leading position in the near future. The rising demand for flat-panel digital detectors is one of the key factors predicted to enhance the growth of the X-ray segment throughout the forecast period. On the other hand, the MRI and CT segments are anticipated to witness a healthy growth, thanks to their non-invasive nature of performing the angiography.

To Obtain All-Inclusive Information On Forecast Analysis Of Angiography Devices Market , Request A Discount

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=40136

Technological Advancements to Encourage Market Growth

The rise in the aging population and the increasing incidence of CVD are the major factors encouraging the growth of the angiography devices market in the next few years. The rising number of awareness programs and increasing funding activities and the growing focus on technological advancements are some of the key factors that are estimated to accelerate the growth of the overall market throughout the forecast period. On the flip side, the risk of radiation exposure and the limitations in the reimbursement for the angiography procedure are projected to restrict the growth of the market in the near future. Nonetheless, the developing economies hold immense growth potential, which is likely to accelerate the growth of the global angiography devices market in the next few years.

posted Feb 11 by Rohini Chaudhari

  Promote This Article
Facebook Share Button Twitter Share Button Google+ Share Button LinkedIn Share Button Multiple Social Share Button

Related Articles
0 votes

Transparency Market Research (TMR) has published a research study on the global renal denervation devices market, expecting it to rise at an exponential CAGR of 41.20% during the period from 2012 to 2021 and reach a value of US$1.9 bn by the end of the forecast period.The market report, titled “Renal Denervation Devices Market – Global Industry Analysis, Size, Share, Growth, and Forecast 2012 – 2021,” further states that the worldwide market for renal denervation devices stood at US$88.5 mn in 2012.

Renal denervation is a relatively new therapy for the treatment of uncontrolled hypertension. It is a minimally invasive procedure and reduces the blood pressure by ablating renal nerves. Hypertension is regarded as a modifiable health risk and is often associated with morbidity and mortality due to its association with cardiovascular diseases. The development of catheter-based interventional therapies to interrupt renal sympathetic nervous system has shown impressive results in ensuring better blood pressure control in patients complaining of resistant hypertension. This, coupled with the increasing prevalence of uncontrolled as well as drug-resistant hypertension, is stimulating the demand for renal denervation procedures in the global arena.

The report has analyzed the global renal denervation devices market on the basis of products, technology, and its regional spread. Symplicity, OneShot, EnligHTN, V2, TIVUS, Paradise, Bullfrog, and Surround Sound have been identified as the main products available in this market.

Get Sample with Latest Research @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=400

Based on technology, this market has been classified into radiofrequency renal denervation devices, micro-infusion renal denervation devices, and ultrasound renal denervation devices.The research report regionally segments the global market for renal denervation devices into Asia Pacific, North America, and the Rest of the World. As per the market study, Europe is the leading regional renal denervation devices market.

In 2012, Europe held a share of 80% in the global renal denervation devices market. Analysts project the region to retain its dominance over the forecast period. The rising research activities in Europe for the further development of renal denervation procedures is fueling the demand from the market in this region.

The Asia Pacific renal denervation devices market has occupied the second position in the global market and is likely to retain its position during the forecast period. The rising geriatric population in Asia Pacific, coupled with a large patient pool suffering from diabetes, is driving the demand for renal denervation devices market in this region, states the market report.

The report also expects the markets for renal denervation devices in North America and the Rest of the world to show healthy growth. The increasing approvals of these devices from the U.S. FDA are driving the North America renal denervation devices market, whereas the Rest of the World market is led by the rising incidence of lifestyle-related cardiovascular disorders, notes the study.

Some of the key manufacturers of renal denervation devices mentioned in this research study are Medtronic Inc., St. Jude Medical, Kona Medical, Boston Scientific Corp., Mercator Medsystems, Covidien Plc., and CardioSonic.

More Trending Reports by Transparency Market Research –

Insulin Pen Needles Market: prnewswire.com/news-releases/insulin-pen-needles-market-to-expand-at-a-cagr-of-8-0-till-2026-rising-need-for-therapeutic-gadgets-to-augment-global-industry—tmr-300855783.html

Bioremediation Technology & Services Market: prnewswire.com/news-releases/bioremediation-technology—services-market-to-reach-us657-bn-by-2025-globally-transparency-market-research-668429603.html

0 votes

The latest report compiled by Transparency Market Research talks about the dynamics of the global radiofrequency (RF) ablation devices for pain management market. As per the report, the radiofrequency ablation devices for pain management market is projected to reach an overall valuation worth US$1,114.5 mn by the end of 2024. This growth of the market is expected to be achieved with the help of a strong CAGR of 12.9% over the course of the given forecast period of 2017 to 2024.

As per the findings of the report published by TMR, the global radiofrequency ablation devices for pain management market was dominated by the end-user segment of hospitals. From a geographical outlook, the market is projected to be led by North America and Europe in the coming years of the forecast period. On the other hand, the Asia Pacific region of the global radiofrequency ablation devices for pain management market is projected to show high growth potential during the forecast period of 2017 to 2024.

Want to know the obstructions to your company’s growth in future? Request a PDF sample here

The competitive landscape of the radiofrequency ablation devices for pain management market is highly consolidated. This is mainly due to the presence of a handful of companies operating in this domain. Some of the key players in the global radiofrequency ablation devices for pain management market include names such as Diros Technology Inc., Halyard Health Inc., St. Jude Medical Inc., Stryker Corporation, and Boston Scientific Corporation among others.

Of these above-mentioned names, St. Jude Medical Inc. has emerged to be a clear market leader. The company boasts a strong and diversified business portfolio, accurate marketing and acquisition strategies, and vast geographical presence. In addition to this, the company has also invested heavily on the research and development to provide efficient and innovating medical equipment and devices to their end users. Boston Scientific Corporation, another leading company in the global radiofrequency ablation devices for pain management market, has immense expertise in offering services that are cost-effective and highly reliable. The company is also trying to invest more in R&D activities to enhance its business portfolio.

To Know the Segments Analyzed in the Radiofrequency Ablation Devices Market Report, Ask for a Brochure here

Growing Geriatric Population Boosting Marketing Growth

There are several factors that are influencing the growth of the global radiofrequency ablation devices market for pain management. One key driving factor for the growth of the global market is the increasing number of geriatrics who suffer from a disorder such as arthritis. As per the findings published by the United Nations in 2017, people over the age of 60 account for nearly 13% of the global population. This number is only expected to grow in the coming years. This is also expected to play an important role in the growth of the global radiofrequency ablation devices for pain management market in the near future.

Another important factor that is driving the growth of the global market is the increasing preference of the patients to undergo minimally invasive surgical procedures. Such procedures offer fast relief and also cut down the number of days in the hospital. Additionally, several industry leaders and investing heavily to enhance current technologies. This is also expected to boost the growth of the market in the near future.

High Compliance Issues Hampering Market Development

A key factor that is slowing down the growth of the global radiofrequency ablation devices for pain management market is the huge compliances associated with the regulations set by the governmental bodies. These ablation devices are a class III medical devices and thus need high compliances. Furthermore, the availability of several other pain relief therapeutics is also hampering the growth of the global radiofrequency ablation devices for pain management market.

0 votes

The global market for patient registry software is likely to get intense with the coming few years, owing to the existence of several players, states a new market research study by Transparency Market Research. The high level of fragmentation and the rising level of competition are estimated to generate potential growth opportunities for the players over the next few years. The expansion of the product portfolio, technological advancements, and innovations are some of the key strategies that have been adopted by the players so as to maintain their dominance over the next few years. In addition to this, the key players are focusing on mergers and acquisitions, thus enhancing the overall development of the market in the next few years. Some of the leading players in the patient registry software market across the globe are Global Vision Technologies, Inc., PatientCrossroads, Evado Clinical Solution, Dacima Software, Inc., and Quintiles, Inc.

As per the research study by TMR, in 2016, the global market for patient registry software stood at US$1 bn and the market is projected to reach US$2 bn by the end of 2023. The market is likely to register a healthy 10.50% CAGR between 2015 and 2023. The patient registry software market across North America is anticipated to account for a large share of the patient registry software market and exhibit a promising growth rate in the coming few years. The rising number of cases of chronic diseases and the presence of favorable reimbursement policies are estimated to enhance the development of this region in the coming few years.

Planning To Lay Down Future Strategy? Request Brochure Of Patient Registry Software Market

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5498

Adoption of Cloud-based Patient Registry Solutions to Support Market Growth

A substantial rise in the adoption of EHRs and the growing use of patient registry data for the surveillance of post-marketing are the key factors that are anticipated to encourage the development of the global patient registry software market in the coming few years. The increasing pressure in order to enhance the quality of care and further reduce the costs of healthcare are projected to supplement the market growth in the next few years.

In addition to this, the implementation of government initiatives for building the patient registries is further predicted to enhance the growth in the near future. Also, the technological developments in this area and the rising use of cloud-based patient registry solutions are estimated to support the growth of the overall market in the next few years. This is expected to encourage the entry of new players, thus enhancing the competitive landscape of the patient registry software market in the coming years.

To Obtain All-Inclusive Information On Forecast Analysis Of Patient Registry Software Market , Request A Discount

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=5498

Lack of Awareness Concerning Benefits of Patient Registry Software to Hamper Growth

The global patient registry software market is expected to face a slight dip in its growth due to a few restraints faced by the players. The lack of skilled resources and the rising concerns related to data privacy and security are some of the major factors restricting the market growth. Moreover, the lack of awareness among people and the reluctance of people concerning the adoption of new and advanced solutions are estimated to curb the growth of the market in the near future. Nonetheless, the rise in the number of accountable care organizations is expected to ensure the development of patient registry software market in the near future.

More Trending Reports by Transparency Market Research –

Back Table and Cart Covers Market –

https://www.prnewswire.com/news-releases/back-table-and-cart-covers-market-to-register-steady-3-2-cagr-during-2019-2027-transparency-market-research-300999428.html

Viral Vector & Plasmid DNA Manufacturing Market – 

https://www.prnewswire.com/news-releases/global-viral-vector–plasmid-dna-manufacturing-market-to-chart-23-3-cagr-from-2019-to-2027-transparency-market-research-301000176.html

0 votes

The global helicobacter pylori (H. pylori) non-invasive testing market was valued at approximately US$ 518.0 Mn in 2017 and is projected to register a compounded annual growth rate (CAGR) of over 3.99% from 2018 to 2026, according to a new report titled, “Helicobacter Pylori (H. pylori) Non-invasive Testing Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”, published by Transparency Market Research (TMR). 

The report suggests that factors, such as, rise in the adoption of non-invasive testing for diagnosis of H. pylori, lack of endoscopic facilities, and upcoming technologically-advanced tests from global market players for non-invasive helicobacter pylori testing in the next few years (2018-2026) are likely to boost the demand for global helicobacter pylori (H. pylori) non-invasive tests. High awareness and diagnosis rate of H. pylori infection in North America and high prevalence of the disease in East-European countries are likely to generate a significant share for the market in North America and Europe from 2018 to 2026.

Rise in adoption of non-invasive tests for H. pylori diagnosis globally to fuel the market

There has been a growing preference for non-invasive tests globally for H. pylori infection testing among patients as well as health care providers, owing to quick turnaround time for test results, higher patient compliance, and reduced discomfort usually associated with invasive tests. At the same time, these tests are high in accuracy and specificity to aid the correct diagnosis of the H. pylori infection. Non-invasive tests are also cost-effective compared to invasive endoscopic options.

Request PDF Sample of Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=45312

Serology test segment to lose market share

Among non-invasive tests, serology test is commonly prescribed by health care practitioners for H. pylori owing to the relatively lower cost and ease of conducting of the test. However, the serology test segment is expected to lose its market share during the forecast period. Regional agencies such as American Gastroenterology Association (AGA) and National Health Services (NHS) have updated their guidelines to prevent the use of serology testing for detection of H. pylori due to high incidence rate of false positives, lower specificity as compared to other non-invasive testing methods, and inability to test for eradication of the H. pylori infection in a patient associated with the test. The serology test segment is estimated to hold a market share of 30.3% by the end of 2018, while its market share is anticipated to drop to 13.7% by the end of 2026.

Laboratory-based tests segment to witness significant growth

Among test methods, the laboratory-based tests segment of the global helicobacter pylori (h. pylori) non-invasive testing market is estimated to witness a significant growth during the forecast period. The segment is likely to expand at a CAGR of 3.73% between 2018 and 2026. Growth of the segment can be ascribed to the fact that a majority of these tests are performed in laboratory settings, based on laboratory methods, conducted by trained professionals in a controlled environment. Laboratories are capable of conducting high volume of tests per day and providing the results in a few hours or a few days (1 to 2 days). According to WHO, in Asia Pacific, an estimated 70% of health decisions are based on laboratory results, as laboratory-based tests provide essential support and facilitate appropriate medical intervention.

Diagnostic laboratories to be highly promising among end-users

Among end users, the diagnostic laboratories segment is expected to hold the leading i.e. 47.5% share of the market by 2026. This can be attributed to the large number of H. pylori non-invasive tests performed by standalone and hospital-based diagnostic laboratories. Moreover, presence of major standalone laboratories, testing a large number of patient, and high adoption of new tests and instruments by diagnostic laboratories for diagnosis of H. pylori, is expected to fuel the growth of the diagnostic laboratories segment through 2026.

Buy Now “Helicobacter Pylori (H. Pylori) Non-invasive Testing Market” Research Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=45312&ltype=S

Asia Pacific to witness significant growth and create high incremental opportunity

The helicobacter pylori (H. pylori) non-invasive testing market in Asia Pacific is estimated to expand at a significant CAGR of 4.52% during the forecast period. The market in the region is likely to be driven by the high prevalence of H. pylori in rural India, (80% or even more), where a vast population is living under poverty and gastric cancer burden, linked to H. pylori bacteria, is relatively high. North America is expected to hold the leading market share of 31.1% by 2026, due to rising incidence of gastric adenocarcinoma, peptic ulcers, and other diseases which are strongly associated with H. pylori infection.

This has prompted national and regional health care agencies in the U.S. to actively promote non-invasive diagnostic tests for chronic as well as acute dyspeptic patients, with an aim to eradicate H. pylori infection from among the prevalent population. The helicobacter pylori (H. pylori) non-invasive testing market in North America is likely to register a CAGR of 3.62% during the forecast period.

Key players to continue leading global helicobacter pylori (H. pylori) non-invasive testing market

Prominent players operating in the global helicobacter pylori (h. pylori) non-invasive testing market are DiaSorin S.p.A., Meridian Bioscience, Inc., Exalenz Bioscience Ltd., Alere, Thermo Fisher Scientific, Biomerica, Inc., Certest Biotec S.L., Sekisui Diagnostics, CorisBioconcept SPRL and Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd. These key players are expected to maintain their key positions during the forecast period.

More Trending Reports by Transparency Market Research –

Personal Mobility Devices Market: prnewswire.com/news-releases/personal-mobility-devices-market-to-touch-us-146-bn-by-2024-propelled-by-rising-preference-for-electric-wheelchairs-a-new-report-by-tmr-589847341.html

Global Wound Healing Market: prnewswire.com/news-releases/global-wound-healing-market-to-reach-over-us-350-billion-by-2025-says-tmr-676809663.html

0 votes

The global helicobacter pylori (H. pylori) non-invasive testing market was valued at approximately US$ 518.0 Mn in 2017 and is projected to register a compounded annual growth rate (CAGR) of over 3.99% from 2018 to 2026, according to a new report titled, “Helicobacter Pylori (H. pylori) Non-invasive Testing Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”, published by Transparency Market Research (TMR).

The report suggests that factors, such as, rise in the adoption of non-invasive testing for diagnosis of H. pylori, lack of endoscopic facilities, and upcoming technologically-advanced tests from global market players for non-invasive helicobacter pylori testing in the next few years (2018-2026) are likely to boost the demand for global helicobacter pylori (H. pylori) non-invasive tests. High awareness and diagnosis rate of H. pylori infection in North America and high prevalence of the disease in East-European countries are likely to generate a significant share for the market in North America and Europe from 2018 to 2026.

Get a Glimpse of the In-Depth Analysis through our Comprehensive “Helicobacter Pylori (H. Pylori) Non-invasive Testing Market” Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=45312

Rise in adoption of non-invasive tests for H. pylori diagnosis globally to fuel the market

There has been a growing preference for non-invasive tests globally for H. pylori infection testing among patients as well as health care providers, owing to quick turnaround time for test results, higher patient compliance, and reduced discomfort usually associated with invasive tests. At the same time, these tests are high in accuracy and specificity to aid the correct diagnosis of the H. pylori infection. Non-invasive tests are also cost-effective compared to invasive endoscopic options.

Serology test segment to lose market share

Among non-invasive tests, serology test is commonly prescribed by health care practitioners for H. pylori owing to the relatively lower cost and ease of conducting of the test. However, the serology test segment is expected to lose its market share during the forecast period. Regional agencies such as American Gastroenterology Association (AGA) and National Health Services (NHS) have updated their guidelines to prevent the use of serology testing for detection of H. pylori due to high incidence rate of false positives, lower specificity as compared to other non-invasive testing methods, and inability to test for eradication of the H. pylori infection in a patient associated with the test. The serology test segment is estimated to hold a market share of 30.3% by the end of 2018, while its market share is anticipated to drop to 13.7% by the end of 2026.

Laboratory-based tests segment to witness significant growth

Among test methods, the laboratory-based tests segment of the global helicobacter pylori (h. pylori) non-invasive testing market is estimated to witness a significant growth during the forecast period. The segment is likely to expand at a CAGR of 3.73% between 2018 and 2026. Growth of the segment can be ascribed to the fact that a majority of these tests are performed in laboratory settings, based on laboratory methods, conducted by trained professionals in a controlled environment. Laboratories are capable of conducting high volume of tests per day and providing the results in a few hours or a few days (1 to 2 days). According to WHO, in Asia Pacific, an estimated 70% of health decisions are based on laboratory results, as laboratory-based tests provide essential support and facilitate appropriate medical intervention.

Diagnostic laboratories to be highly promising among end-users

Among end users, the diagnostic laboratories segment is expected to hold the leading i.e. 47.5% share of the market by 2026. This can be attributed to the large number of H. pylori non-invasive tests performed by standalone and hospital-based diagnostic laboratories. Moreover, presence of major standalone laboratories, testing a large number of patient, and high adoption of new tests and instruments by diagnostic laboratories for diagnosis of H. pylori, is expected to fuel the growth of the diagnostic laboratories segment through 2026.

Asia Pacific to witness significant growth and create high incremental opportunity

The helicobacter pylori (H. pylori) non-invasive testing market in Asia Pacific is estimated to expand at a significant CAGR of 4.52% during the forecast period. The market in the region is likely to be driven by the high prevalence of H. pylori in rural India, (80% or even more), where a vast population is living under poverty and gastric cancer burden, linked to H. pylori bacteria, is relatively high. North America is expected to hold the leading market share of 31.1% by 2026, due to rising incidence of gastric adenocarcinoma, peptic ulcers, and other diseases which are strongly associated with H. pylori infection. This has prompted national and regional health care agencies in the U.S. to actively promote non-invasive diagnostic tests for chronic as well as acute dyspeptic patients, with an aim to eradicate H. pylori infection from among the prevalent population. The helicobacter pylori (H. pylori) non-invasive testing market in North America is likely to register a CAGR of 3.62% during the forecast period.

Key players to continue leading global helicobacter pylori (H. pylori) non-invasive testing market

Prominent players operating in the global helicobacter pylori (h. pylori) non-invasive testing market are DiaSorin S.p.A., Meridian Bioscience, Inc., Exalenz Bioscience Ltd., Alere, Thermo Fisher Scientific, Biomerica, Inc., Certest Biotec S.L., Sekisui Diagnostics, CorisBioconcept SPRL and Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd. These key players are expected to maintain their key positions during the forecast period.

More Trending Reports by Transparency Market Research –

Hearing Aids Market: prnewswire.com/news-releases/hearing-aids-market-increasing-prevalence-of-hearing-loss-worldwide-augments-product-demand-says-tmr-300857268.html

Global Wound Healing Market: prnewswire.com/news-releases/global-wound-healing-market-to-reach-over-us-350-billion-by-2025-says-tmr-676809663.html

...